SBIR/STTR Research Award
IGF::OT::IGF -- Biomarkers for Alcohol and ALD
Award amount
$625,360Program and phase
SBIR · Phase IIAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ECHELON BIOSCIENCES, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- EDK8FFD24SC4
- Solicitation number
- Not reported
- Topic code
- NIAAA
Research abstract
This contract addresses the need for reliable and accurate biomarkers of alcohol consumption, initially in response to a National Institute on Alcohol Abuse and Alcoholism (NIAAA)-initiated Small Business Innovation Research (SBIR) contract topic on Biomarkers for Alcohol-induced Disorders. The goals of this contract are to advance the usefulness of phosphatidylethanol (PEth), an alcohol metabolite, as a clinical biomarker of alcohol consumption, by designing an antibody-based method of quantitation that ischeaper and more accessible to small hospitals and clinics than currently used chromatographic/ spectrophotometric methods. This contract is a continuation of a Phase II SBIR contract with Echelon Biosciences, Inc. It was awarded under SBIR solicitation PHS-2008-1, Topic 031. This effort is deemed to be non-severable. PUBLIC HEALTH RELEVANCE
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Innovative Point-of-Care Solutions for Long-term Alcohol Biomarkers
- Optimized Platforms for Proper Glycosylation and Sialylation of Recombinant Human Butyrylcholinesterase (rBChE)
- Accessible And Robust Tools for Glycosaminoglycan Profiling
- Transgenic Black Soldier Flies for Sustainable, Improved Nutrition
- Transgenic black soldier flies for sustainable, improved nutrition
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Developing natural compound emodin as a therapy for alcoholic cardiomyopathy
- DEVELOPMENT OF NOVEL PDE4B INHIBITORS TO TREAT ALCOHOL USE DISORDER (SBIR PHASE II)
- SBIR PHASE I - WEARABLE BIOSENSOR THAT QUANTIFIES BLOOD ALCOHOL CONCENTRATION IN REAL TIME
- THIS SBIR PHASE I CONTRACT IS FOR A WEARABLE ALCOHOL BIOSENSOR THAT QUANTIFIES BAC IN REAL TIME.
- Detection and Staging of Liver Fibrosis by Precise MRI (pMRI)
Research funding history
40 SBIR/STTR records share this UEI (1998–2024). Reported award amounts total $11,763,634. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation